Search

Mr. Chiaraviglio received his B.S. from Harvard University and M.S. from the University of Chicago. He has worked previously as a systems engineer, programming project consultant, and software test engineer for companies such as Miranova, Laserlith, and Ziatech/Intel, and was a Principal...

Dr. Kang received his Ph.D. from Korea University studying bacterial hydrocarbon degradation by several model organisms in the laboratory of Professor Professor Woojun Park. He then performed postdoctoral work on the genetic regulation of microbial arsenic metabolism in the laboratory of Professor...

Matthew is a now a junior biochemistry major at Northeastern. He joined the laboratory in January 2025 as a sophomore Co-Op student where he helped develop an alternative to agar dilution technology for reference antimicrobial susceptibility testing and to investigate the MexY efflux pump protein...

Heidi joined us in the summer of 2024. A Harvard College sophomore, Heidi is growing vast quantities of Streptomyces with much aeration and fanfare to induce them to produce copious quantities of antimicrobials amongst other biological feats in the laboratory! Outside of the laboratory Heidi loves...

Katie will be joining the laboratory in July 2026 to study antimicrobial resistance. She is currently an Infectious Disease Fellow in the combined MGH/BWH program. She received her MD/PhD from the Albert Einstein College of Medicine where she did PhD work in Bill Jacob's laboratory.

Alhanouf is a medicinal chemist by training who completed her PhD in the laboratory of our close collaborator, George O'Doherty, at Northeastern University. In the Kirby lab, she will be pursuing projects related to antimicrobial development and characterization under a prestigious KAUST fellowship...

Yanqin joined the laboratory In January 2022 after after perfecting analysis in two compartment models in the Laboratory of Zachery P. Bulman at the University of Illinois. In previous ventures, she was instrumental in the development of the MRX-1, also known as Contezalid, a new oxazalidinone...

Dr. Kirby is an NIH-funded Principal Investigator in the Experimental Pathology Division of Beth Israel Deaconess Medical Center; Professor of Pathology at Harvard Medical School, and Director of the Clinical Microbiology Laboratory at BIDMC; He is also a Fellow of the American Academy of...